Literature DB >> 26027615

Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: A transesophageal echocardiographic study.

Kenichi Sugioka1, Masahiko Takagi2, Shinichi Sakamoto3, Suwako Fujita2, Asahiro Ito2, Shinichi Iwata2, Yoshiki Matsumura2, Masashi Nakagawa2, Atsushi Doi2, Yukio Miki3, Minoru Yoshiyama2, Makiko Ueda4.   

Abstract

BACKGROUND: Silent brain infarction (SBI) is often found in patients with atrial fibrillation (AF) and may be related to cognitive decline. We investigated the predictors of SBI on brain magnetic resonance imaging (MRI) using transesophageal echocardiography (TEE) in patients with nonvalvular AF.
METHODS: The study population consisted of 103 neurologically asymptomatic patients with nonvalvular AF who underwent TEE before transcatheter AF ablation (76 men; mean age 63 ± 10 years). Left atrial (LA) abnormalities such as LA thrombus, spontaneous echo contrast, or abnormal LA appendage emptying velocity (<20 cm/s) and complex plaques in the aortic arch defined as large plaques ≥4 mm thickness, ulcerated plaques, or mobile plaques were evaluated by TEE. All patients were screened for SBI by brain MRI.
RESULTS: Of 103 patients, 31 (30%) showed SBI on brain MRI. Most lesions were multiple (61%) and small (<15 mm) in diameter (84%). Patients with SBI had a higher prevalence of LA abnormalities (45% vs 14%; P < .001) and complex arch plaques (45% vs 7%; P < .001) compared with those without SBI. In a multivariate logistic regression analysis including age and CHADS2 score ≥2, LA abnormalities (odds ratio 4.13; 95% CI 1.34-12.72; P = .014) and complex arch plaques (odds ratio 4.82; 95% CI 1.23-18.92; P = .024) were independent predictors of SBI.
CONCLUSIONS: Left atrial abnormalities and complex arch plaques detected by TEE were closely associated with the presence of SBI on brain MRI, suggesting that microembolization of small thrombi derived from the fibrillating LA or advanced aortic atherosclerotic lesions may be important causes of SBI in patients with nonvalvular AF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26027615     DOI: 10.1016/j.ahj.2015.03.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease.

Authors:  Aylin Tugcu; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Mitsuhiro Yoshita; Charles DeCarli; Koki Nakanishi; Sofia Shames; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Stroke       Date:  2016-10-11       Impact factor: 7.914

2.  Difference in risk factors of silent brain infarction between paroxysmal and persistent atrial fibrillation.

Authors:  Andrew T Kim; Shinichi Iwata; Sera Ishikawa; Soichiro Tamura; Masanori Matsuo; Tomotaka Yoshiyama; Shinichi Nonin; Asahiro Ito; Yasuhiro Izumiya; Minoru Yoshiyama
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-18

3.  Clinical Significance of the Left Atrial Appendage Orifice Area.

Authors:  Yusuke Miki; Yasuhiro Uchida; Akihito Tanaka; Akihiro Tobe; Keisuke Sakakibara; Takashi Kataoka; Kiyoshi Niwa; Kenji Furusawa; Hitoshi Ichimiya; Junji Watanabe; Masaaki Kanashiro; Hideki Ishii; Satoshi Ichimiya; Toyoaki Murohara
Journal:  Intern Med       Date:  2021-11-13       Impact factor: 1.282

4.  Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.

Authors:  André Rodrigues Durães; Pollianna de Souza Roriz; Bianca de Almeida Nunes; Felipe Pinho E Albuquerque; Fábio Vieira de Bulhões; Andre Mauricio de Souza Fernandes; Roque Aras
Journal:  Drugs R D       Date:  2016-06

5.  MRI-detected brain lesions in AF patients without further stroke risk factors undergoing ablation - a retrospective analysis of prospective studies.

Authors:  Juliane Herm; Johannes Schurig; Martin R Martinek; Reinhard Höltgen; Alexander Schirdewan; Paulus Kirchhof; Marcus Wieczorek; Helmut Pürerfellner; Peter U Heuschmann; Jochen B Fiebach; Karl Georg Haeusler
Journal:  BMC Cardiovasc Disord       Date:  2019-03-12       Impact factor: 2.298

6.  Silent stroke in patients with atrial fibrillation: Prevalence and predictive factors.

Authors:  Manel Ben Halima; Khaled Ezzaouia; Selim Boudiche; Bassem Rekik; Fathia Mghaieth; Sana Ouali; Asma Zidi; Mohamed Sami Mourali
Journal:  Tunis Med       Date:  2021 Avril

7.  Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure.

Authors:  Yangyang Jiang; Lei Wang; Ziwen Lu; Shiqi Chen; Yu Teng; Tong Li; Yang Li; Yingzhen Xie; Mingjing Zhao
Journal:  Front Cardiovasc Med       Date:  2022-01-26

8.  Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.

Authors:  Jie Zheng; Meng Wang; Qun-Feng Tang; Feng Xue; Ku-Lin Li; Shi-Peng Dang; Xiao-Yu Liu; Xiao-Xi Zhao; Chang-Ying Zhang; Zhi-Ming Yu; Bing Han; Ting-Bo Jiang; Yan Yao; Ru-Xing Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-01

Review 9.  Atrial fibrillation and silent stroke: links, risks, and challenges.

Authors:  Kathrin Hahne; Gerold Mönnig; Alexander Samol
Journal:  Vasc Health Risk Manag       Date:  2016-03-07

10.  Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation.

Authors:  Masayuki Suzuki; Kohei Furuya; Misato Ozawa; Kumiko Miura; Tadashi Ozawa; Kosuke Matsuzono; Takafumi Mashiko; Reiji Koide; Shigeru Fujimoto; Ryota Tanaka
Journal:  J Atheroscler Thromb       Date:  2020-09-10       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.